Comparative study of zinc levels in benign and malignant lesions of the prostate

Scandinavian Journal of Urology and Nephrology

Volumn 40, Issue 2, 2006, Pages 108-112

  Goel, Tanmaya ^a   Sankhwar, S N ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Benign; Malignant; Prostate; Prostatic disease; Zinc

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BENIGN TUMOR; CHRONIC PROSTATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; FIBROMUSCULAR PROSTATE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATE METASTASIS; SCREENING TEST; ZINC BLOOD LEVEL;

BIOLOGICAL MARKERS; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; REFERENCE VALUES; ZINC;

EID: 33646258765     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590500368922     Document Type: Article

References (17)

1. Elizabeth GW. Plasma zinc levels in prostate diseases. Br J Urol 1975;41:295-9.
2. Schrodt GR, Hall T, Whitmore WF. Changes in zinc levels in BPH. Cancer 1964;17:1555-6.
3. Dhar NK. Studies on subcellular distribution and concentration of zinc in hyperplastic and neoplastic prostate. Br J Exp Pathol 1973;19:139-42.
4. Mawson CA, Fischer MI. Zonal distribution of zinc in human prostate. Can J Med Sci 1952;30:336.
5. Brys M, Nawrocka AD, Miekos E, Zydek C, Foksinski M, Barecki A, et al. Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res 1997;59:145-52.
6. Feustel A, Wennrich R, Schmidt B. Serum-Zn-levels in prostatic cancer. Urol Res 1989;17:41-2.
7. Whelan P, Walker BE, Kelleher J. Zinc, vitamin A and prostate cancer. Br J Urol 1983;55:525-8.
8. Willden EG, Robinson MR. Plasma zinc levels in prostatic disease. Br J Urol 1975;47:295-9.
9. Zaichick VYe, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 1997;29:565-74.
10. Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999;8:887-92.
11. Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO. Diet and benign prostatic hyperplasia: a study in Greece. Urology 1999;54:284-90.
12. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998;35:285-96.
13. Iguchi K, Hamatake M, Ishida R, Usami Y, Adachi T, Yamamoto H, et al. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem 1998;253:766-70.
14. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999;40:200-7.
15. Feng P, Liang JY, Li TL, Guan ZX, Zou J, Franklin R, et al. Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 2000;4:31-6.
16. Feustel A, Wennrich R. Determination of the distribution of zinc and cadmium in cellular fractions of BPH, normal prostate, and prostatic cancers of different histologies by atomic and laser absorption spectrometry in tissue slices. Urol Res 1984;12:253-6.
17. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2003;95:1004-6.